Cite

HARVARD Citation

    Gohil, S. et al. (n.d.). Preclinical development of novel humanised ROR1 targeting chimeric antigen receptor T cells and bispecific T-cell engagers. Lancet. pp. S40-. [Online]. 
  
Back to record